サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439234

末梢血管デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
末梢血管デバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢血管デバイスの市場規模は、2023年に96億3,000万米ドル、2030年までに151億3,000万米ドルに達し、2024年～2030年の予測期間にCAGRで7.88％の成長が見込まれます。末梢血管デバイスの需要は、主に心血管疾患や末梢血管疾患の有病率の上昇、新製品や先進製品の承認、糖尿病や高血圧などの生活習慣病の罹患率の上昇によって後押しされています。さらに、老年人口の増加も末梢血管デバイス市場の成長に寄与する可能性が高いです。

末梢血管デバイスの市場力学

British Heart Foundation（2022）によると、2019年に全世界で約5億5,000万人が心臓および循環器の疾患を患っています。American Heart Association（2022）で公開されたデータによると、2020年に世界中で約2億4,410万人が冠動脈（虚血性）心疾患を抱えて生活していました。同資料はさらに、北アフリカ、中東、中央アジア、南アジア、東欧は2020年の冠動脈（虚血性）心疾患の有病率がもっとも高かったと述べています。

欧州心臓病学会（ESC）（2023）によると、毎年、欧州では心血管疾患（CVD）が390万人の死因となっており、欧州連合（EU）では180万人以上が死亡しています。欧州では全死亡の約45％、EUでは37％を占めています。世界保健機関（WHO）（2023）のデータでは、世界中で約12億8,000万人が高血圧に苦しんでいます。高血圧は深刻な病状であり、末梢動脈疾患を含む血管障害の主な危険因子です。したがって、心血管疾患とその危険因子の有病率の上昇により、末梢血管デバイス市場は予測期間に高成長を記録すると予測されます。

しかし、頻繁な製品の不具合やリコール、厳しい製品承認プロセスが、予測期間に末梢血管デバイス市場の成長を抑制する可能性があります。

末梢血管デバイス市場のセグメント分析

末梢血管デバイス市場の製品タイプセグメントでは、PTAバルーンカテーテルセグメントの薬剤溶出カテゴリが予測期間に最大の市場シェアを占めると予測されます。これは、薬剤溶出性バルーンカテーテルが提供する利点によるものです。これらのカテーテルは動脈の狭窄を効果的に改善し、血流を改善します。このカテーテルはもっとも安全で、合併症も少なく、回復も早いとされています。

薬剤溶出性バルーンカテーテルは、薬剤粒子を血管壁に即座に、均質に、持続的に放出します。このバルーンは単独でもベアメタルステントとの併用でも問題なく使用できます。これらのバルーンは、細胞分裂を阻害する可能性を保持するように考案されており、その結果、治療後の再狭窄、すなわち閉塞の再増殖を抑制するのに役立っています。

したがって、薬剤溶出性PTAバルーンカテーテルが提供するさまざまな利点が、この製品タイプに対する需要の増加に寄与し、末梢血管デバイス市場全体の成長を促進すると予測されます。

北米が末梢血管デバイス市場全体を独占すると予測されます。

全地域の中で北米が末梢血管デバイス市場で最大のシェアを獲得する見込みです。心血管疾患の有病率の増加、よりよい医療インフラへのアクセス、そしてこの地域における主要市場企業のプレゼンスが、予測期間に市場全体の成長を促進する主な影響要因になると予測されています。

米国疾病予防管理センター（CDC）（2023）のデータによると、米国では毎年約90万人が深部静脈血栓症（DVT）または肺塞栓症（PE）に罹患していると推定されています。2021年の米国心臓協会は、2035年までに米国の成人1億3,000万人以上が何らかの心臓疾患に罹患すると予測しています。CDC（2021）によると、2019年に米国で約2,870万人が糖尿病を患っていました。糖尿病（DM）は心血管系疾患の主な危険因子であり、死亡率の上昇を招くだけでなく、疾患の進行を早めることが立証されています。

当レポートでは、世界の末梢血管デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 末梢血管デバイス市場レポートのイントロダクション

第2章 末梢血管デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 末梢血管デバイス市場の主な要因の分析

  • 末梢血管デバイス市場の促進要因
    • 生活習慣病の増加
    • 末梢血管疾患の有病率の増加
    • 低侵襲手術に対する需要の高まり
    • 新製品開発につながる技術の進歩
  • 末梢血管デバイス市場の抑制要因と課題
    • 頻繁に起こる製品の故障とリコール
    • 厳格な製品承認プロセス
  • 末梢血管デバイス市場の機会
    • 新興市場をターゲットにした製品の発売
    • 製品の安全性向上

第5章 末梢血管デバイス市場のポーターのファイブフォース分析

第6章 末梢血管デバイス市場のレイアウト

  • 製品タイプ別
    • PTAバルーンカテーテル
    • 血管形成術用ステント
    • 血小板修正デバイス
    • 血行力学的フロー調整デバイス
    • 下大静脈フィルター
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
  • 地域別
    • 北米の末梢血管デバイスの市場規模（2021年～2030年）
    • 欧州の末梢血管デバイスの市場規模（2021年～2030年）
    • アジア太平洋の末梢血管デバイスの市場規模（2021年～2030年）
    • その他の地域の末梢血管デバイスの市場規模（2021年～2030年）

第7章 末梢血管デバイスの企業と製品のプロファイル

  • Medtronic
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Braile Biomedica
  • JOTEC GmbH
  • Edwards Life Sciences Corporation
  • LeMaitre Vascular, Inc
  • W. L. Gore & Associates, Inc
  • Abbott
  • Cardiovascular Systems Inc
  • AngioDynamics Inc
  • Control Medical Technology, LLC
  • Walk Vascular, LLC
  • Transit Scientific
  • Conic Vascular

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Peripheral Vascular Devices Market in Global (2021-2030)
  • Table 3: Peripheral Vascular Devices Market in Global by Product Type (2021-2030)
  • Table 4: Peripheral Vascular Devices Market in Global by End-User (2021-2030)
  • Table 5: Peripheral Vascular Devices Market in Global by Geography (2021-2030)
  • Table 7: Peripheral Vascular Devices Market in North America (2021-2030)
  • Table 11: Peripheral Vascular Devices Market in the US (2021-2030)
  • Table 12: Peripheral Vascular Devices Market in Canada (2021-2030)
  • Table 13: Peripheral Vascular Devices Market in Mexico (2021-2030)
  • Table 14: Peripheral Vascular Devices Market in Europe (2021-2030)
  • Table 18: Peripheral Vascular Devices Market in France (2021-2030)
  • Table 19: Peripheral Vascular Devices Market in Germany (2021-2030)
  • Table 20: Peripheral Vascular Devices Market in the United Kingdom (2021-2030)
  • Table 21: Peripheral Vascular Devices Market in Italy (2021-2030)
  • Table 22: Peripheral Vascular Devices Market in Spain (2021-2030)
  • Table 24: Peripheral Vascular Devices Market in Rest of Europe (2021-2030)
  • Table 25: Peripheral Vascular Devices Market in APAC (2021-2030)
  • Table 29: Peripheral Vascular Devices Market in China (2021-2030)
  • Table 30: Peripheral Vascular Devices Market in Japan (2021-2030)
  • Table 31: Peripheral Vascular Devices Market in India (2021-2030)
  • Table 32: Peripheral Vascular Devices Market in Australia (2021-2030)
  • Table 33: Peripheral Vascular Devices Market in South Korea (2021-2030)
  • Table 34: Peripheral Vascular Devices Market in Rest of APAC (2021-2030)
  • Table 35: Peripheral Vascular Devices Market in the Rest of the World (2021-2030)
  • Table 39: Peripheral Vascular Devices Market in the Middle East (2021-2030)
  • Table 40: Peripheral Vascular Devices Market in Africa (2021-2030)
  • Table 41: Peripheral Vascular Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Peripheral Vascular Devices Market in Global (2021-2030)
  • Figure 3: Peripheral Vascular Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Peripheral Vascular Devices Market in Global by End-User (2021-2030)
  • Figure 5: Peripheral Vascular Devices Market in Global by Geography (2021-2030)
  • Figure 6: Peripheral Vascular Devices Market in North America (2021-2030)
  • Figure 7: Peripheral Vascular Devices Market in the US (2021-2030)
  • Figure 8: Peripheral Vascular Devices Market in Canada (2021-2030)
  • Figure 9: Peripheral Vascular Devices Market in Mexico (2021-2030)
  • Figure 10: Peripheral Vascular Devices Market in Europe (2021-2030)
  • Figure 11: Peripheral Vascular Devices Market in France (2021-2030)
  • Figure 12: Peripheral Vascular Devices Market in Germany (2021-2030)
  • Figure 13: Peripheral Vascular Devices Market in the United Kingdom (2021-2030)
  • Figure 14: Peripheral Vascular Devices Market in Italy (2021-2030)
  • Figure 15: Peripheral Vascular Devices Market in Spain (2021-2030)
  • Figure 16: Peripheral Vascular Devices Market in Rest of Europe (2021-2030)
  • Figure 17: Peripheral Vascular Devices Market in APAC (2021-2030)
  • Figure 18: Peripheral Vascular Devices Market in China (2021-2030)
  • Figure 19: Peripheral Vascular Devices Market in Japan (2021-2030)
  • Figure 20: Peripheral Vascular Devices Market in India (2021-2030)
  • Figure 21: Peripheral Vascular Devices Market in Australia (2021-2030)
  • Figure 22: Peripheral Vascular Devices Market in South Korea (2021-2030)
  • Figure 23: Peripheral Vascular Devices Market in Rest of APAC (2021-2030)
  • Figure 24: Peripheral Vascular Devices Market in the Rest of the World (2021-2030)
  • Figure 25: Peripheral Vascular Devices Market in the Middle East (2021-2030)
  • Figure 26: Peripheral Vascular Devices Market in Africa (2021-2030)
  • Figure 27: Peripheral Vascular Devices Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0019

Peripheral Vascular Devices Market By Product Type (Percutaneous Transluminal Angioplasty Balloon Catheters [Normal, Drug-Eluting, Cutting, and Scoring], Angioplasty Stents [Drug-Eluting, Bare-Metal, and Expandable], Plaque Modification Devices [Arthrectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Vena cava Filters [Retrieavable And Permanent], and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular and peripheral vascular diseases.

The global peripheral vascular devices market was valued at USD 9.63 billion in 2023, growing at a CAGR of 7.88% during the forecast period from 2024 to 2030, to reach USD 15.13 billion by 2030. The demand for peripheral vascular devices is primarily being boosted by the rising prevalence of cardiovascular diseases and peripheral vascular diseases, the approval of new and advanced products, and the rising incidence of lifestyle disorders such as diabetes and hypertension. Furthermore, the increase in the geriatric population is also likely to contribute to the peripheral vascular devices market growth.

Peripheral Vascular Devices Market Dynamics:

According to British Heart Foundation 2022, worldwide around 550 million people were suffering from heart and circulatory diseases in 2019. As per the data published by American Heart Association 2022, about 244.1 million people were living with coronary (ischemic) heart disease in 2020 across the world. The same source further mentioned that North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates for coronary (ischemic) heart disease in 2020.

According to the European Society for Cardiology (ESC) (2023), each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU. As per the data provided by the World Health Organization (WHO) 2023, about 1.28 billion people across the globe are suffering from hypertension. It is a serious medical condition and a major risk factor for vascular disorders including peripheral artery disease. Therefore, the peripheral vascular devices market is expected to register high growth in the forecast period due to the rising prevalence of cardiovascular diseases and their risk factors.

However, frequent product failures and recalls and stringent product approval processes may restrain the growth of this peripheral vascular devices market during the forecast period.

Peripheral Vascular Devices Market Segment Analysis:

Peripheral Vascular Devices by Product Type (PTA Balloon Catheters [Normal, Drug-Eluting, Cutting, and Scoring], Angioplasty Stents [Drug-Eluting, Bare-Metal, and Expandable], Plaque Modification Devices [Arthrectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Venacava Filters [Retrievable and Permanent], and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the peripheral vascular devices market, the drug-eluting category under the PTA balloon catheters segment is expected to account for the largest market share during the forecast period. This can be attributed to the advantages offered by drug-eluting balloon catheters. These catheters lead to an effective reduction in the narrowing of arteries, resulting in improved blood flow. It is considered as one of the safest approaches with minimal procedural complications, and faster recovery periods.

Drug-eluting balloon catheters offer immediate, homogenous, and sustained release of drug particles to the vessel wall. They can be used alone or in combination with a bare metal stent without many issues. These balloons are devised in such a way that they hold the potential to inhibit cell division which in turn helps in limiting the amount of restenosis, or blockage re-growth after treatment.

Therefore, various advantages offered by the drug-eluting PTA balloon catheters, are predicted to contribute to the increasing demand for this product type, thereby driving the growth of the overall peripheral vascular devices market.

North America is expected to dominate the overall Peripheral Vascular Devices Market:

Among all the regions, North America is expected to amass the largest share of the peripheral vascular devices market. The growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region are predicted to be the major influencing factors in driving the overall growth of the market over the forecast period.

According to the Centers for Disease Control and Prevention (CDC) 2023 data, it has been estimated that approximately 900,000 people are affected by deep vein thrombosis (DVT) or pulmonary embolism (PE) each year in the United States. The American Heart Association in 2021 projected that by 2035, more than 130 million US adults will have some sort of heart disease. As per CDC 2021, around 28.7 million people in the US had diabetes in 2019. It has been established that diabetes mellitus (DM) is a major risk factor for cardiovascular diseases, which leads to increased mortality and as well as hastens the disease progression course.

Furthermore, in October 2020, Boston Scientific Corporation received FDA clearance for Ranger(TM) Paclitaxel-Coated PTA Balloon Catheter which is a drug-coated balloon. It is deployed in the re-opening of the blocked or narrowed arteries in the thigh and knee due to peripheral artery disease (PAD).

Considering the presence of a large patient pool in the US coupled with new product launches, the market for peripheral vascular devices looks promising in the United States, and subsequently in North America.

Key Peripheral Vascular Devices Companies Market:

Some of the key peripheral vascular devices companies operating in the market include Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., AngioDynamics Inc, Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular, and others.

Recent Developmental Activities in Peripheral Vascular Devices Market:

In June 2021, AngioDynamics Inc received 510k clearance from the US Food and Drug Administration for their AlphaVac Mechanical Thrombectomy System. The device is an off-circuit, multi-purpose mechanical aspiration thrombectomy system which is deployed in the non-surgical removal of emboli or thrombi from the vasculature.

In May 2021, Transit Scientific received the CE Mark clearance in the European Union for the XO Score® Scoring Sheath Platform. This device facilitates the dilation of stenotic material in the peripheral vasculature including infrapopliteal, popliteal, and native or synthetic arteriovenous dialysis fistulae.

In January 2021, Cardiovascular Systems, Inc. received the CE Mark for Diamondback 360® Coronary Orbital Atherectomy System. It combines differential sanding and pulsatile forces to treat all calcium modalities, including eccentric (irregular), nodular, and concentric (ring-shaped).

Key Takeaways from the Peripheral Vascular Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the peripheral vascular devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global Peripheral Vascular Devices Market.

Various opportunities are available for the other competitor in the Peripheral Vascular Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current peripheral vascular devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for peripheral vascular devices market growth in the coming future?

Target audience who can be benefited from This Peripheral Vascular Devices Market Report Study

Peripheral Vascular Devices products providers

Research organizations and consulting companies

Peripheral Vascular Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in peripheral vascular devices

Various End-users who want to know more about the Peripheral Vascular Devices market and the latest technological developments in the Peripheral Vascular Devices market.

Frequently Asked Questions for Peripheral Vascular Devices Market:

What is a Peripheral Vascular Device?

A peripheral vascular device is a medical device that helps in the treatment of blockages and narrowing of the arteries specifically in the peripheral vasculature.

What is the market for Global Peripheral Vascular Devices?

Global Peripheral Vascular Devices Market was valued at USD 9.63 billion in 2023, growing at a CAGR of 7.88% during the forecast period from 2024 to 2030, to reach USD 15.13 billion by 2030.

What are the drivers for Global Peripheral Vascular Devices Market?

The major drivers of the peripheral vascular devices market are the increasing prevalence of cardiovascular diseases as well as peripheral vascular diseases, the growing elderly population, and technological innovation in product development.

What are the key players operating in Global Peripheral Vascular Devices Market?

Some of the prominent market players operating in the peripheral vascular devices market includes Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., AngioDynamics Inc, Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular and others.

What region has the highest share in the Peripheral Vascular Devices market?

North America is expected to account for the largest revenue share in the overall peripheral vascular devices market during the forecast period, 2024 to 2030. This high growth in the market can be attributed to the increasing prevalence of cardiovascular diseases, conducive healthcare system and policies in the region, especially in the US.

Table of Contents

1. Peripheral Vascular Devices Market Report Introduction

2. Peripheral Vascular Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Peripheral Vascular Devices Market Key Factors Analysis

  • 4.1. Peripheral Vascular Devices Market Drivers
    • 4.1.1. Rising Incidence of Lifestyle Disorders
    • 4.1.2. Increasing Prevalence of Peripheral Vascular Diseases
    • 4.1.3. Growing Demand for Minimally-Invasive Procedures
    • 4.1.4. Technological Advancements Leading to New Product Development
  • 4.2. Peripheral Vascular Devices Market Restraints and Challenges
    • 4.2.1. Frequent Product Failures and Recalls
    • 4.2.2. Stringent Product Approval Process
  • 4.3. Peripheral Vascular Devices Market Opportunities
    • 4.3.1. Targeting Emerging Markets for Product Launches
    • 4.3.2. Product Improvement in Terms of Safety

5. Peripheral Vascular Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Peripheral Vascular Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. PTA Balloon Catheters
      • 6.1.1.1. Normal
      • 6.1.1.2. Drug-Eluting
      • 6.1.1.3. Cutting
      • 6.1.1.4. Scoring
    • 6.1.2. Angioplasty Stents
      • 6.1.2.1. Drug-Eluting
      • 6.1.2.2. Bare-Metal
      • 6.1.2.3. Expandable
    • 6.1.3. Plaque Modification Devices
      • 6.1.3.1. Atherectomy Devices
      • 6.1.3.2. Thrombectomy Devices
    • 6.1.4. Hemodynamic Flow Alteration Devices
      • 6.1.4.1. Embolic Protection Devices
      • 6.1.4.2. Chronic Total Occlusion Devices
    • 6.1.5. Inferior Venacava Filters
      • 6.1.5.1. Retrievable
      • 6.1.5.2. Permanent
    • 6.1.6. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals
    • 6.2.2. Ambulatory Surgical Centers
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.1.1. United States Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.1.2. Canada Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.1.3. Mexico Peripheral Vascular Devices Market Size in USD million (2021-2030)
    • 6.3.2. Europe Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.1. France Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.2. Germany Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.3. United Kingdom Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.4. Italy Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.5. Spain Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.2.6. Rest of Europe Peripheral Vascular Devices Market Size in USD million (2021-2030)
    • 6.3.3. Asia-Pacific Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.1. China Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.2. Japan Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.3. India Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.4. Australia Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.5. South Korea Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.3.6. Rest of Asia-Pacific Peripheral Vascular Devices Market Size in USD million (2021-2030)
    • 6.3.4. Rest of the World (RoW) Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.4.1. Middle East Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.4.2. Africa Peripheral Vascular Devices Market Size in USD million (2021-2030)
      • 6.3.4.3. South America Peripheral Vascular Devices Market Size in USD million (2021-2030)

7. Peripheral Vascular Devices Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Boston Scientific Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. B. Braun Melsungen AG
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Braile Biomedica
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. JOTEC GmbH
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Edwards Life Sciences Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. LeMaitre Vascular, Inc
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. W. L. Gore & Associates, Inc
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Abbott
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Cardiovascular Systems Inc
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. AngioDynamics Inc
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Control Medical Technology, LLC
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Walk Vascular, LLC
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Transit Scientific
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Conic Vascular
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us